Septerna Strengthens Leadership Team to Advance Novel Small Molecule GPCR Medicines
Read More
Septerna 250 East Grand Avenue, Suite 65 South San Francisco, CA 94080
Posts by septerna
Fierce Biotech: Septerna emerges with $100M to spark ‘second golden age’ of prolific drug target GPCR with pioneer as co-founder
Read More
ENDPOINTS: A new Third Rock startup seeks a ‘second golden age’ of GPCR drug discovery based on Nobel laureate’s work
Read More
Septerna Launches with $100 Million Series A Financing to Expand the Frontier of GPCR-targeted Medicines using the Native Complex™ Platform
Read More
Privacy Policy
Read More
Terms of Use
Read More